Cargando…
Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability
Successful cancer therapy is contingent on identifying cancer-specific aberrant phenotypes and their associated vulnerabilities. We recently reported that a subset of almost every cancer type contains a genome-wide defect in RNA Polymerase II-mediated transcription elongation (TE(def)), which impair...
Autores principales: | Muhammad, B., Parks, L.G., Komurov, K., Privette Vinnedge, L.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718660/ https://www.ncbi.nlm.nih.gov/pubmed/34954455 http://dx.doi.org/10.1016/j.tranon.2021.101323 |
Ejemplares similares
-
Defective transcription elongation in a subset of cancers confers immunotherapy resistance
por: Modur, Vishnu, et al.
Publicado: (2018) -
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022) -
Proteotoxic Stress as an Exploitable Vulnerability in Cells with Hyperactive AKT
por: Babagana, Mahamat, et al.
Publicado: (2021) -
Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
por: Greene, Allie N., et al.
Publicado: (2020) -
Editorial: Targeting Cardiac Proteotoxicity
por: Ranek, Mark J., et al.
Publicado: (2021)